HER-2 amplification is highly homogenous in gastric cancer-reply

Human Pathology

Volumn 41, Issue 2, 2010, Pages 305-306

  Marx, Andreas H ^a   Simon, Ronald ^a   Sauter, Guido ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTIFACT; BREAST CANCER; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; LETTER; ONCOGENE NEU; PROGNOSIS; SCORING SYSTEM; STAINING; STOMACH CANCER;

EID: 73749086788     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.10.007     Document Type: Letter

References (8)

1. Marx A.H., Tharun L., Muth J., et al. HER-2 amplification is highly homogenous in gastric cancer. Hum Pathol 40 (2009) 769-777
2. Sauter G., Lee J., Bartlett J.M., Slamon D.J., and Press M.F. Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations. J Clin Oncol 27 (2009) 1323-1333
3. Sauter G., Moch H., Moore D., et al. Heterogeneity of erbB-2 gene amplification in bladder cancer. Cancer Res 53 (1993) 2199-2203
4. Sauter G., Simon R., and Hillan K. Tissue microarrays in drug discovery. Nat Rev Drug Discov 2 (2003) 962-972
5. Torhorst J., Bucher C., Kononen J., et al. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 159 (2001) 2249-2256
6. Sauter G., and Mirlacher M. Tissue microarrays for predictive molecular pathology. J Clin Pathol 55 (2002) 575-576
7. Simon R., Mirlacher M., and Sauter G. Tissue microarrays in cancer diagnosis. Expert Rev Mol Diagn 3 (2003) 421-430
8. Press M.F., Sauter G., Bernstein L., et al. Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials. Clin Cancer Res 11 (2005) 6598-6607